The Complete Nucleotide Sequence of the Carbapenem Resistance-Conferring Conjugative Plasmid pLD209 from a Pseudomonas putida Clinical Strain Reveals a Chimeric Design Formed by Modules Derived from Both Environmental and Clinical Bacteria | Zendy

Patricia Marchiaro | Zendy; Luciano Brambilla | Zendy; Jorgelina Morán-Barrio | Zendy; Santiago Revale | Zendy; Fernando Pasterán | Zendy; Alejandro J. Vila | Zendy; Alejandro M. Viale | Zendy; Adriana S. Limansky | Zendy

Open Access

The Complete Nucleotide Sequence of the Carbapenem Resistance-Conferring Conjugative Plasmid pLD209 from a Pseudomonas putida Clinical Strain Reveals a Chimeric Design Formed by Modules Derived from Both Environmental and Clinical Bacteria

Author(s) -

Patricia Marchiaro,

Luciano Brambilla,

Jorgelina Morán-Barrio,

Santiago Revale,

Fernando Pasterán,

Alejandro J. Vila,

Alejandro M. Viale,

Adriana S. Limansky

Publication year - 2014

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02494-13

Subject(s) - pseudomonas putida , plasmid , biology , integron , strain (injury) , genetics , bacteria , microbiology and biotechnology , horizontal gene transfer , pseudomonas , gene , multilocus sequence typing , nucleic acid sequence , phylogenetic tree , genotype , anatomy

The complete sequence of the carbapenem-resistance-conferring conjugative plasmid pLD209 from a Pseudomonas putida clinical strain is presented. pLD209 is formed by 3 well-defined regions: an adaptability module encompassing a Tn402-like class 1 integron of clinical origin containing blaVIM-2 and aacA4 gene cassettes, partitioning and transfer modules, and a replication module derived from plasmids of environmental bacteria. pLD209 is thus a mosaic of modules originating in both the clinical and environmental (nonclinical) microbiota.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research